Nekulova, Mirka

Predicting response of ovarian cancer to paclitaxel treatment based on trend analysis of serum CA125. [electronic resource] - Clinical chemistry Aug 2002 - 1364-7 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0009-9147


Adult
Aged
Antineoplastic Agents, Phytogenic--therapeutic use
CA-125 Antigen--blood
Female
Humans
Middle Aged
Neoplasm Recurrence, Local
Ovarian Neoplasms--diagnosis
Paclitaxel--therapeutic use
Prognosis
Prospective Studies
Reference Values